Categories LATEST

Gilead Sciences Q3 2023 Earnings: Stay tuned for the live earnings call and real-time transcript

Gilead Sciences, Inc. (NASDAQ: GILD), a leading research-based biopharmaceutical company, will be reporting third-quarter results today at 4:00 p.m. ET.


Listen to Gilead Sciences earnings call live and check the real-time transcript


Analysts’ consensus estimate for September-quarter earnings is $1.81 per share, on an adjusted basis, which marks a decline from $1.90 per share the company earned in the year-ago quarter. Revenue is expected to be $6.42 billion, up 4.8% year-over-year.

For the second quarter, the company reported total revenue of $6.6 billion, which is up 5% year-over-year. Net income attributable to Gilead was $1 billion or $0.83 per share in Q2, compared to $1.1 billion, or $0.91 per share last year. Adjusted EPS decreased 15% to $1.34.

Listen to the conference calls as they happen. Don't miss a beat! With AlphaStreet Intelligence, you can listen to live calls and interviews as they happen, so you never have to worry about missing out on important information.

Most Popular

Infographic: How Macy’s (M) performed in Q4 2023 financial results

Macy’s, Inc. (NYSE: M) reported fourth quarter 2023 earnings results today. Net sales were $8.1 billion, down 1.7% versus the same period a year ago. Total revenue dropped to $8.37

AZO Earnings: AutoZone’s Q2 2024 earnings rise on higher sales

AutoZone, Inc. (NYSE: AZO) announced financial results for the second quarter of 2024, reporting higher sales and net profit. The company had a total of 7,191 stores open at the end

SJM Earnings: Key quarterly highlights from J.M. Smucker’s Q3 2024 financial results

The J.M. Smucker Co. (NYSE: SJM) reported third quarter 2024 earnings results today. Net sales increased 1% year-over-year to $2.23 billion. Organic sales increased 6%. Net income decreased 42% to

Add Comment
Loading...
Cancel
Viewing Highlight
Loading...
Highlight
Close
Top